Hims & Hers stock rises as FDA schedules peptide review BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide Pharmacy Times FDA Peptide Reclassification 2026 Amanecia Health